1. Home
  2. GRFS vs INSP Comparison

GRFS vs INSP Comparison

Compare GRFS & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • INSP
  • Stock Information
  • Founded
  • GRFS 1940
  • INSP 2007
  • Country
  • GRFS Spain
  • INSP United States
  • Employees
  • GRFS N/A
  • INSP N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • INSP Medical/Dental Instruments
  • Sector
  • GRFS Health Care
  • INSP Health Care
  • Exchange
  • GRFS Nasdaq
  • INSP Nasdaq
  • Market Cap
  • GRFS 6.2B
  • INSP 3.8B
  • IPO Year
  • GRFS 2006
  • INSP 2018
  • Fundamental
  • Price
  • GRFS $9.82
  • INSP $132.73
  • Analyst Decision
  • GRFS Hold
  • INSP Buy
  • Analyst Count
  • GRFS 1
  • INSP 12
  • Target Price
  • GRFS $10.30
  • INSP $213.75
  • AVG Volume (30 Days)
  • GRFS 803.7K
  • INSP 600.5K
  • Earning Date
  • GRFS 01-01-0001
  • INSP 08-04-2025
  • Dividend Yield
  • GRFS N/A
  • INSP N/A
  • EPS Growth
  • GRFS N/A
  • INSP N/A
  • EPS
  • GRFS 0.31
  • INSP 2.17
  • Revenue
  • GRFS $7,968,532,207.00
  • INSP $840,111,000.00
  • Revenue This Year
  • GRFS $7.14
  • INSP $20.61
  • Revenue Next Year
  • GRFS $7.16
  • INSP $17.32
  • P/E Ratio
  • GRFS $39.36
  • INSP $60.16
  • Revenue Growth
  • GRFS 10.76
  • INSP 27.11
  • 52 Week Low
  • GRFS $6.19
  • INSP $123.00
  • 52 Week High
  • GRFS $9.96
  • INSP $225.00
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 72.22
  • INSP 57.93
  • Support Level
  • GRFS $8.84
  • INSP $126.74
  • Resistance Level
  • GRFS $9.19
  • INSP $136.33
  • Average True Range (ATR)
  • GRFS 0.23
  • INSP 5.46
  • MACD
  • GRFS 0.06
  • INSP 1.48
  • Stochastic Oscillator
  • GRFS 95.66
  • INSP 74.78

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Share on Social Networks: